Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Part of paid clinical trials in San Diego, California.
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study ID
- NCT00553501
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- epratuzumab — BIOLOGICALDays 1, 8, 15, 22 and weeks 12, 20, 28, \& 36: 360mg/sq m IV
- rituximab — BIOLOGICALDay 3, 8, 15, 22 and weeks 12, 20, 28, \& 36: 375mg/sq m IV
Study Details
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving epratuzumab and rituximab together may be more effective in treating follicular non-Hodgkin lymphoma. PURPOSE: This phase II trial is studying how well giving epratuzumab together with rituximab works in treating patients with previously untreated follicular non-Hodgkin lymphoma.
Key Dates
- Start date
- Mar 31, 2008
- Status verified
- Jul 2016
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2014
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Epratuzumab Plus RituximabInduction Therapy (Month 1): Epratuzumab 360 mg/m\^2 by IV days 1, 8, 15 \& 22; Rituximab 375 mg/m\^2 by IV day 3, 8, 15 \& 22 Extended Induction (Weeks 12, 20, 28 \& 36) Epratuzumab 360 mg/m\^2 by IV weeks 12, 20, 28 \& 36; Rituximab 375 mg/m\^2 by IV weeks 12, 20, 28 \& 36
Primary Outcome Measure
Number of Participants With Overall Response [ Time Frame: 12 months ]
Locations (43)
Find similar trials in San Diego, CA
By research site
Kaiser Permanente Medical Office -Vandever Medical Office· San Diego, CAUCSF Helen Diller Family Comprehensive Cancer Center· San Francisco, CAMiddlesex Hospital Cancer Center· Middletown, CTTunnell Cancer Center at Beebe Medical Center· Lewes, DECCOP - Christiana Care Health Services· Newark, DELombardi Comprehensive Cancer Center at Georgetown University Medical Center· Washington D.C., DC
Related Studies
- Bone Marrow Grafting for Leukemia and LymphomaEnrolling By Invitation · Stanford University · Stanford, California
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerRecruiting · Barbara Ann Karmanos Cancer Institute · Detroit, Michigan
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina